ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

October 20, 1995

NCI Halts Routine P01 Site Visits Due to Travel Cut

February 7, 1992

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003

Centers’ Problems Get Increasing Attention From Staff, Advisors

August 20, 1976

Farber Grant Probe Misses Real Story

July 8, 1977